A new venture of Mehta Pharmaceutical Industries, state-of-the-art facility conforming to USFDA /CGMP/UK-MHRA/EDQM & TGA standards
(Under its newly formed Mehta API Pvt. Ltd.) to manufacture APIs just commissioned. Spread across a sprawling 26,580 Sq M, this facility will have dedicated blocks for the manufacturing of APIs.
Erythromycin Derivatives, Azithromycine and its Intermediates, Intermediates of Clarithromycin & Dirithromycin.
Multipurpose facility with Kilo Lab/ Pilot Plant to be commissioned shortly. Separate quality control and quality assurance departments manned by qualified personnel and backed by a well equipped modern laboratory. Seeks strategic alliance from innovator. Generic & dossier companies globally for APIs & Advanced Intermediates.
- Contract Research & Manufacturing of APIs and Intermediates
- Regulatory services